Learning Objectives

August 1-2, 2008

New York, NY

• Describe the current status of state-of-the-art therapies of lung cancer, including chemotherapy and radiation therapy

• Discuss the management of subhistologies of NSCLC

• Define the current status of multimodality therapy in the treatment of localized and advanced lung cancer

• Outline the clinical data supporting the use of EGFR inhibitors in the treatment of lung cancer

• Review agents that target angiogenesis in lung cancer, including the safety profile and efficacy

• Specify the impact of multi-targeted kinase inhibitors in the management of lung cancer

• Describe novel therapeutic agents that potentially improve upon standard chemotherapeutics

• Cite recent data on surgical advances in non?small-cell lung cancer

• Define the importance of supportive care in the management of lung cancer